SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F BEIJING, May 16, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA)(“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it is delaying its]